共 25 条
- [1] Garcon N(2003)Development of RTS, S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant Expert Rev Vaccines 2 231-238
- [2] Heppner DG(2009)The development of the RTS, S malaria vaccine candidate: challenges and lessons Parasite Immunol 31 492-500
- [3] Cohen J(2009)Long-term safety and efficacy of the RTS, S/AS02A malaria vaccine in Mozambican children J Infect Dis 200 329-336
- [4] Ballou WR(2007)Safety and immunogenicity of the RTS, S/AS02A candidate malaria vaccine in children aged 1–4 in Mozambique Trop Med Int Health 12 37-46
- [5] Sacarlal J(2006)Phase 1 safety and immunogenicity trial of malaria vaccine RTS, S/AS02A in adults in a hyperendemic region of western Kenya Am J Trop Med Hyg 75 166-170
- [6] Aide P(2005)Duration of protection with RTS, S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial Lancet 366 2012-2018
- [7] Aponte JJ(2005)Safety and immunogenicity of RTS, S/AS02A candidate malaria vaccine in Gambian children Vaccine 23 4148-4157
- [8] Macete E(2003)Protective immunity induced with malaria vaccine, RTS, S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma J Immunol 171 6961-6967
- [9] Aponte JJ(2009)Evaluation of RTS, S/AS02A and RTS, S/AS01B in adults in a high malaria transmission area PLoS One 4 e6465-undefined
- [10] Guinovart C(undefined)undefined undefined undefined undefined-undefined